Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 30, 2015 Filed Nov 3, 2015 23:01 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 200 | $126.86 | $25,372.00 |
DisclosureSEC source: 0001209191-15-078176 · doc4.xml · nonDerivative · entry 5 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,923 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $126.86 (range $126.85 to $126.87). Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 23:01 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 8,125 | $126.31 | $1,026,268.75 |
DisclosureSEC source: 0001209191-15-078176 · doc4.xml · nonDerivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,123 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $126.31 (range $125.85 to $126.81). Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 23:01 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 4,800 | $125.35 | $601,680.00 |
DisclosureSEC source: 0001209191-15-078176 · doc4.xml · nonDerivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,248 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $125.35 (range $124.85 to $125.84). Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 23:01 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 1,400 | $124.33 | $174,062.00 |
DisclosureSEC source: 0001209191-15-078176 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,048 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $124.33 (range $123.83 to $124.74). Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 23:01 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 1,600 | $123.34 | $197,344.00 |
DisclosureSEC source: 0001209191-15-078176 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,448 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $123.34 (range $122.82 to $123.79). Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 23:02 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 4,500 | $126.31 | $568,395.00 |
DisclosureSEC source: 0001209191-15-078177 · doc4.xml · nonDerivative · entry 4 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,748 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $126.31 (range $125.86 to $126.78). Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 23:02 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 3,950 | $125.30 | $494,935.00 |
DisclosureSEC source: 0001209191-15-078177 · doc4.xml · nonDerivative · entry 3 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,248 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $125.30 (range $124.85 to $125.82). Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 23:02 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 1,000 | $124.44 | $124,440.00 |
DisclosureSEC source: 0001209191-15-078177 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,198 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $124.44 (range $123.85 to $124.80). Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 23:02 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 900 | $123.36 | $111,024.00 |
DisclosureSEC source: 0001209191-15-078177 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,198 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $123.36 (range $122.82 to $123.62). Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 23:04 UTC |
Sachdev AmitEVP, Policy, Access & Value
|
SaleCommon Stock | 1,100 | $126.61 | $139,271.00 |
DisclosureSEC source: 0001209191-15-078180 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · EVP, Policy, Access & Value 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,963 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $126.61 (range $126.44 to $126.75). Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 23:04 UTC |
Sachdev AmitEVP, Policy, Access & Value
|
SaleCommon Stock | 2,638 | $126.01 | $332,414.38 |
DisclosureSEC source: 0001209191-15-078180 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · EVP, Policy, Access & Value 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,063 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $126.01 (range $125.43 to $126.39). Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 23:04 UTC |
Sachdev AmitEVP, Policy, Access & Value
|
SaleCommon Stock | 1,500 | $124.94 | $187,410.00 |
DisclosureSEC source: 0001209191-15-078180 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP, Policy, Access & Value 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,701 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $124.94 (range $124.40 to $125.37). Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 23:04 UTC |
Sachdev AmitEVP, Policy, Access & Value
|
SaleCommon Stock | 700 | $123.34 | $86,338.00 |
DisclosureSEC source: 0001209191-15-078180 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, Policy, Access & Value 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,201 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $123.34 (range $123.06 to $123.66). Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 23:03 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 2,685 | $126.62 | $339,974.70 |
DisclosureSEC source: 0001209191-15-078179 · doc4.xml · nonDerivative · entry 3 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,784 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $126.62 (range $126.34 to $126.93). Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 23:03 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 4,865 | $125.98 | $612,892.70 |
DisclosureSEC source: 0001209191-15-078179 · doc4.xml · nonDerivative · entry 2 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,469 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $125.98 (range $125.33 to $126.28). Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 23:03 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 2,800 | $124.95 | $349,860.00 |
DisclosureSEC source: 0001209191-15-078179 · doc4.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,334 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $124.95 (range $124.33 to $125.30). Read SEC document |
| October 28, 2015 Filed Oct 30, 2015 14:31 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,400 | $0.00 Strike: $35.64 | $0.00 |
DisclosureSEC source: 0001209191-15-077347 · doc4.xml · derivative · entry 9 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,000 Underlying: Common Stock · 10,400 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Fully vested. Read SEC document |
| October 28, 2015 Filed Oct 30, 2015 14:31 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 100 | $121.47 | $12,147.00 |
DisclosureSEC source: 0001209191-15-077347 · doc4.xml · nonDerivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,284 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Read SEC document |
| October 28, 2015 Filed Oct 30, 2015 14:31 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 2,600 | $120.18 | $312,468.00 |
DisclosureSEC source: 0001209191-15-077347 · doc4.xml · nonDerivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,384 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $120.18 (range $119.71 to $120.65). Read SEC document |
| October 28, 2015 Filed Oct 30, 2015 14:31 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 4,356 | $119.10 | $518,799.60 |
DisclosureSEC source: 0001209191-15-077347 · doc4.xml · nonDerivative · entry 4 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,984 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $119.10 (range $118.71 to $119.64). Read SEC document |
| October 28, 2015 Filed Oct 30, 2015 14:31 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 2,144 | $118.30 | $253,635.20 |
DisclosureSEC source: 0001209191-15-077347 · doc4.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,340 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $118.30 (range $117.65 to $118.52). Read SEC document |
| October 28, 2015 Filed Oct 30, 2015 14:31 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 1,200 | $117.25 | $140,700.00 |
DisclosureSEC source: 0001209191-15-077347 · doc4.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,484 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $117.25 (range $116.65 to $117.53). Read SEC document |
| October 28, 2015 Filed Oct 30, 2015 14:31 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 10,400 | $35.64 | $370,656.00 |
DisclosureSEC source: 0001209191-15-077347 · doc4.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2015 Filed Oct 23, 2015 21:01 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,400 | $0.00 Strike: $35.64 | $0.00 |
DisclosureSEC source: 0001209191-15-076600 · doc4.xml · derivative · entry 10 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,400 Underlying: Common Stock · 10,400 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Fully vested. Read SEC document |
| October 21, 2015 Filed Oct 23, 2015 21:01 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 300 | $112.00 | $33,600.00 |
DisclosureSEC source: 0001209191-15-076600 · doc4.xml · nonDerivative · entry 7 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,284 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $112.00 (range $112.00 to $112.01). Read SEC document |
| October 21, 2015 Filed Oct 23, 2015 21:01 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 1,000 | $110.98 | $110,980.00 |
DisclosureSEC source: 0001209191-15-076600 · doc4.xml · nonDerivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,584 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $110.98 (range $110.75 to $111.54). Read SEC document |
| October 21, 2015 Filed Oct 23, 2015 21:01 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 2,000 | $110.08 | $220,160.00 |
DisclosureSEC source: 0001209191-15-076600 · doc4.xml · nonDerivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,584 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $110.08 (range $109.64 to $110.56). Read SEC document |
| October 21, 2015 Filed Oct 23, 2015 21:01 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 1,396 | $109.14 | $152,359.44 |
DisclosureSEC source: 0001209191-15-076600 · doc4.xml · nonDerivative · entry 4 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,584 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $109.14 (range $108.64 to $109.63). Read SEC document |
| October 21, 2015 Filed Oct 23, 2015 21:01 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 4,404 | $108.03 | $475,764.12 |
DisclosureSEC source: 0001209191-15-076600 · doc4.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,980 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $108.03 (range $107.59 to $108.58). Read SEC document |
| October 21, 2015 Filed Oct 23, 2015 21:01 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 1,300 | $106.85 | $138,905.00 |
DisclosureSEC source: 0001209191-15-076600 · doc4.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,384 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $106.85 (range $106.58 to $107.18). Read SEC document |
| October 21, 2015 Filed Oct 23, 2015 21:01 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 10,400 | $35.64 | $370,656.00 |
DisclosureSEC source: 0001209191-15-076600 · doc4.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 14, 2015 Filed Oct 16, 2015 19:31 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,400 | $0.00 Strike: $35.64 | $0.00 |
DisclosureSEC source: 0001209191-15-075707 · doc4.xml · derivative · entry 9 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,800 Underlying: Common Stock · 10,400 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| October 14, 2015 Filed Oct 16, 2015 19:31 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 400 | $114.60 | $45,840.00 |
DisclosureSEC source: 0001209191-15-075707 · doc4.xml · nonDerivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,284 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $114.60 (range $114.40 to $114.84). Read SEC document |
| October 14, 2015 Filed Oct 16, 2015 19:31 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 2,500 | $113.64 | $284,100.00 |
DisclosureSEC source: 0001209191-15-075707 · doc4.xml · nonDerivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,684 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $113.64 (range $113.30 to $114.10). Read SEC document |
| October 14, 2015 Filed Oct 16, 2015 19:31 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 3,924 | $112.81 | $442,666.44 |
DisclosureSEC source: 0001209191-15-075707 · doc4.xml · nonDerivative · entry 4 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,184 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $112.81 (range $112.29 to $113.25). Read SEC document |
| October 14, 2015 Filed Oct 16, 2015 19:31 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 2,676 | $111.76 | $299,069.76 |
DisclosureSEC source: 0001209191-15-075707 · doc4.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,108 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $111.76 (range $111.24 to $112.20). Read SEC document |
| October 14, 2015 Filed Oct 16, 2015 19:31 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 900 | $110.58 | $99,522.00 |
DisclosureSEC source: 0001209191-15-075707 · doc4.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,784 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $110.58 (range $110.15 to $110.86). Read SEC document |
| October 14, 2015 Filed Oct 16, 2015 19:31 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 10,400 | $35.64 | $370,656.00 |
DisclosureSEC source: 0001209191-15-075707 · doc4.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2015 Filed Oct 9, 2015 21:16 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,400 | $0.00 Strike: $35.64 | $0.00 |
DisclosureSEC source: 0001209191-15-075102 · doc4.xml · derivative · entry 9 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,200 Underlying: Common Stock · 10,400 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| October 07, 2015 Filed Oct 9, 2015 21:16 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 1,400 | $111.93 | $156,702.00 |
DisclosureSEC source: 0001209191-15-075102 · doc4.xml · nonDerivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,284 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $111.93 (range $111.52 to $112.42). Read SEC document |
| October 07, 2015 Filed Oct 9, 2015 21:16 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 2,500 | $110.67 | $276,675.00 |
DisclosureSEC source: 0001209191-15-075102 · doc4.xml · nonDerivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,684 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $110.67 (range $110.24 to $111.09). Read SEC document |
| October 07, 2015 Filed Oct 9, 2015 21:16 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 1,300 | $109.60 | $142,480.00 |
DisclosureSEC source: 0001209191-15-075102 · doc4.xml · nonDerivative · entry 4 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,184 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $109.60 (range $109.24 to $110.23). Read SEC document |
| October 07, 2015 Filed Oct 9, 2015 21:16 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 4,300 | $108.74 | $467,582.00 |
DisclosureSEC source: 0001209191-15-075102 · doc4.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,484 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $108.74 (range $108.20 to $109.11). Read SEC document |
| October 07, 2015 Filed Oct 9, 2015 21:16 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 900 | $107.23 | $96,507.00 |
DisclosureSEC source: 0001209191-15-075102 · doc4.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,784 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $107.23 (range $106.92 to $107.69). Read SEC document |
| October 07, 2015 Filed Oct 9, 2015 21:16 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 10,400 | $35.64 | $370,656.00 |
DisclosureSEC source: 0001209191-15-075102 · doc4.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2015 Filed Oct 6, 2015 20:40 UTC |
ULLIAN ELAINEDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $34.24 | $0.00 |
DisclosureSEC source: 0001209191-15-074366 · doc4.xml · derivative · entry 3 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2020-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| October 02, 2015 Filed Oct 6, 2015 20:40 UTC |
ULLIAN ELAINEDirector
|
SaleCommon Stock | 20,000 | $110.00 | $2,200,000.00 |
DisclosureSEC source: 0001209191-15-074366 · doc4.xml · nonDerivative · entry 2 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,265 F1 · shares: Transaction made pursuant to M. Ullian's company approved trading plan under Rule 10b5-1. Read SEC document |
| October 02, 2015 Filed Oct 6, 2015 20:40 UTC |
ULLIAN ELAINEDirector
|
Exercise / conversionCommon Stock | 20,000 | $34.24 | $684,800.00 |
DisclosureSEC source: 0001209191-15-074366 · doc4.xml · nonDerivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,265 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2015 Filed Oct 6, 2015 00:15 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 600 | $106.07 | $63,642.00 |
DisclosureSEC source: 0001209191-15-074184 · doc4.xml · nonDerivative · entry 5 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,098 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $106.07 (range $105.99 to $106.12). Read SEC document |
| October 01, 2015 Filed Oct 6, 2015 00:15 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 5,058 | $105.41 | $533,163.78 |
DisclosureSEC source: 0001209191-15-074184 · doc4.xml · nonDerivative · entry 4 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,698 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $105.41 (range $104.91 to $105.90). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.